Please assess the completion status of the following clinical trial:

Trial Title: Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age: 8-17~* BD type I or II comorbid with ADHD~* Baseline score in the YMRS \> or = 20~Exclusion Criteria:~* IQ \< 70~* Pharmacologic treatment in the last month~* Pregnancy or absence of a contraceptive method in fertile girls~* Diagnoses: pervasive development disorder, schizophrenia, drug abuse or dependency~* Risk of suicide or homicide~* Clinical condition that might interfere in the study~* Known sensibility to aripiprazole

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).